Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Greg Crowther, Ph.D.
More GEN Content From This Contributor
- Feature Articles: NGS Advances Spawn Novel Challenges
- Feature Articles: Biomarker Discovery Methods Evolving
- Feature Articles: Cell Culture Moves into Third Dimension
- Feature Articles: Sequencing Hones In on Targets
- Feature Articles: Protein Production Prowess Progresses
- Feature Articles: Ready, Aim, CRISPR (or RNAi)